Article Details

Lupus Nephritis Market to Witness Growth by (2022-2032), Estimates DelveInsight | Key Companies

Retrieved on: 2022-12-14 16:10:09

Tags for this article:

Click the tags to see associated articles and topics

Lupus Nephritis Market to Witness Growth by (2022-2032), Estimates DelveInsight | Key Companies. View article details on HISWAI: https://www.digitaljournal.com/pr/lupus-nephritis-market-to-witness-growth-by-2022-2032-estimates-delveinsight-key-companies-aurinia-pharmaceuticals-roche-astrazeneca-boehringer-ingelheim-novartis-novartis-pharmace

Excerpt

Ravulizumab: Alexion Pharmaceuticals • Anifrolumab: AstraZeneca • Itolizumab: Equillium. Lupus Nephritis Market Dynamics

Article found on: www.digitaljournal.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up